ID

30000

Descripción

Efficacy and Safety of Amlodipine and Losartan in Patients With Essential Hypertension; ODM derived from: https://clinicaltrials.gov/show/NCT00942344

Link

https://clinicaltrials.gov/show/NCT00942344

Palabras clave

Versiones (1)
  1. 3/5/18 3/5/18 -
Titular de derechos de autor

See clinicaltrials.gov

Subido en

3 de mayo de 2018

DOI

Para solicitar uno, por favor iniciar sesión.

Licencia

Creative Commons BY 4.0
Comentarios del modelo :

Puede comentar sobre el modelo de datos aquí. A través de las burbujas de diálogo en los grupos de elementos y elementos, puede agregar comentarios específicos.

Volver a los comentarios del modelo
Comentarios de grupo de elementos para :

Comentarios del elemento para :

Para descargar modelos de datos, debe haber iniciado sesión. Por favor iniciar sesión o Registrate gratis.

Eligibility Hypertension NCT00942344

Inglés

Eligibility Hypertension NCT00942344

1 formularios  
Inclusion Criteria
Descripción

Inclusion Criteria

Alias
UMLS CUI
C1512693
patients aged between 18 and 75
Descripción

Age

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0001779
patients with essential hypertension {95 mmhg ≤ sitdbp< 115 mmhg at the end of placebo run-in treatment period}
Descripción

Essential Hypertension | Sitting diastolic blood pressure

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0085580
UMLS CUI [2]
C1319894
Exclusion Criteria
Descripción

Exclusion Criteria

Alias
UMLS CUI
C0680251
patients with mean sitsbp ≥ 200 mmhg
Descripción

Sitting systolic blood pressure mean

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C1319893
UMLS CUI [1,2]
C0444504
patients with known hypersensitivity to dihydropyridine or angiotensin ii receptor blockers
Descripción

Hypersensitivity Dihydropyridines | Allergy to angiotensin II receptor antagonist

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0020517
UMLS CUI [1,2]
C0012315
UMLS CUI [2]
C2585204
patients with secondary hypertension or suspected secondary hypertension
Descripción

Secondary hypertension | Secondary hypertension Suspected

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0155616
UMLS CUI [2,1]
C0155616
UMLS CUI [2,2]
C0750491
patients with malignant hypertension
Descripción

Malignant Hypertension

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0020540
patients who have received any medications with possible interactions with study drugs
Descripción

Pharmaceutical Preparations Interactions Possible Investigational New Drugs

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0013227
UMLS CUI [1,2]
C0687133
UMLS CUI [1,3]
C0332149
UMLS CUI [1,4]
C0013230
patients with uncontrolled diabetes
Descripción

Diabetic - poor control

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0421258
patients with severe heart disease or severe cerebrovascular disease
Descripción

Heart Disease Severe | Cerebrovascular Disorder Severe

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0018799
UMLS CUI [1,2]
C0205082
UMLS CUI [2,1]
C0007820
UMLS CUI [2,2]
C0205082
patients with clinically significant hematological test results, renal disease (serum creatinine) or liver disease (alt or ast)
Descripción

Test Result Hematologic Clinical Significance | Kidney Disease | Creatinine measurement, serum | Liver disease | Alanine aminotransferase measurement | Aspartate aminotransferase measurement

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C0456984
UMLS CUI [1,2]
C0205488
UMLS CUI [1,3]
C2826293
UMLS CUI [2]
C0022658
UMLS CUI [3]
C0201976
UMLS CUI [4]
C0023895
UMLS CUI [5]
C0201836
UMLS CUI [6]
C0201899
patients with a history of malignant disease
Descripción

Malignant disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0442867
patients with a history of autoimmune disease
Descripción

Autoimmune Disease

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0004364
women with a positive pregnancy test result, breast feeding or intention of pregnancy during the trial
Descripción

Pregnancy test positive | Breast Feeding | Pregnancy, Planned

Tipo de datos

boolean

Alias
UMLS CUI [1]
C0240802
UMLS CUI [2]
C0006147
UMLS CUI [3]
C0032992
patients inappropriate to be included in study population due to other reasons at the discretion of the investigator
Descripción

Other Reason Study Subject Participation Status Inappropriate

Tipo de datos

boolean

Alias
UMLS CUI [1,1]
C3840932
UMLS CUI [1,2]
C2348568
UMLS CUI [1,3]
C1548788
Volver a la parte superior de la página

Similar models

Eligibility Hypertension NCT00942344

1 formularios
Name
Tipo
Description | Question | Decode (Coded Value)
Tipo de datos
Alias
Item Group
C1512693 (UMLS CUI)
Age
Item
patients aged between 18 and 75
boolean
C0001779 (UMLS CUI [1])
Essential Hypertension | Sitting diastolic blood pressure
Item
patients with essential hypertension {95 mmhg ≤ sitdbp< 115 mmhg at the end of placebo run-in treatment period}
boolean
C0085580 (UMLS CUI [1])
C1319894 (UMLS CUI [2])
Item Group
C0680251 (UMLS CUI)
Sitting systolic blood pressure mean
Item
patients with mean sitsbp ≥ 200 mmhg
boolean
C1319893 (UMLS CUI [1,1])
C0444504 (UMLS CUI [1,2])
Hypersensitivity Dihydropyridines | Allergy to angiotensin II receptor antagonist
Item
patients with known hypersensitivity to dihydropyridine or angiotensin ii receptor blockers
boolean
C0020517 (UMLS CUI [1,1])
C0012315 (UMLS CUI [1,2])
C2585204 (UMLS CUI [2])
Secondary hypertension | Secondary hypertension Suspected
Item
patients with secondary hypertension or suspected secondary hypertension
boolean
C0155616 (UMLS CUI [1])
C0155616 (UMLS CUI [2,1])
C0750491 (UMLS CUI [2,2])
Malignant Hypertension
Item
patients with malignant hypertension
boolean
C0020540 (UMLS CUI [1])
Pharmaceutical Preparations Interactions Possible Investigational New Drugs
Item
patients who have received any medications with possible interactions with study drugs
boolean
C0013227 (UMLS CUI [1,1])
C0687133 (UMLS CUI [1,2])
C0332149 (UMLS CUI [1,3])
C0013230 (UMLS CUI [1,4])
Diabetic - poor control
Item
patients with uncontrolled diabetes
boolean
C0421258 (UMLS CUI [1])
Heart Disease Severe | Cerebrovascular Disorder Severe
Item
patients with severe heart disease or severe cerebrovascular disease
boolean
C0018799 (UMLS CUI [1,1])
C0205082 (UMLS CUI [1,2])
C0007820 (UMLS CUI [2,1])
C0205082 (UMLS CUI [2,2])
Test Result Hematologic Clinical Significance | Kidney Disease | Creatinine measurement, serum | Liver disease | Alanine aminotransferase measurement | Aspartate aminotransferase measurement
Item
patients with clinically significant hematological test results, renal disease (serum creatinine) or liver disease (alt or ast)
boolean
C0456984 (UMLS CUI [1,1])
C0205488 (UMLS CUI [1,2])
C2826293 (UMLS CUI [1,3])
C0022658 (UMLS CUI [2])
C0201976 (UMLS CUI [3])
C0023895 (UMLS CUI [4])
C0201836 (UMLS CUI [5])
C0201899 (UMLS CUI [6])
Malignant disease
Item
patients with a history of malignant disease
boolean
C0442867 (UMLS CUI [1])
Autoimmune Disease
Item
patients with a history of autoimmune disease
boolean
C0004364 (UMLS CUI [1])
Pregnancy test positive | Breast Feeding | Pregnancy, Planned
Item
women with a positive pregnancy test result, breast feeding or intention of pregnancy during the trial
boolean
C0240802 (UMLS CUI [1])
C0006147 (UMLS CUI [2])
C0032992 (UMLS CUI [3])
Other Reason Study Subject Participation Status Inappropriate
Item
patients inappropriate to be included in study population due to other reasons at the discretion of the investigator
boolean
C3840932 (UMLS CUI [1,1])
C2348568 (UMLS CUI [1,2])
C1548788 (UMLS CUI [1,3])
Volver a la parte superior de la página 

Contacto

Utilice este formulario para comentarios, preguntas y sugerencias.

Los campos marcados con * son obligatorios.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial